NeurAxis Announces Publication Of Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation With A Blue Cross Blue Shield License In FL
Portfolio Pulse from Benzinga Newsdesk
NeurAxis has announced the publication of a medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS) with a Blue Cross Blue Shield license in Florida. This development could potentially expand the market for NeurAxis' medical devices.
May 16, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NeurAxis has secured medical policy coverage for its Percutaneous Electrical Nerve Field Stimulation (PENFS) with Blue Cross Blue Shield in Florida. This could lead to increased adoption and sales of their medical devices.
The medical policy coverage by a major insurer like Blue Cross Blue Shield in Florida is likely to increase the adoption of NeurAxis' PENFS devices. This could lead to higher sales and revenue for the company in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100